Revision of the EU paediatric and orphan Regulations: 6 key recommendations for Paediatric Cancers
Revision of the EU Paediatric and Orphan Regulations: 6 key recommendations for Paediatric Cancers In the context of the EU’s Pharmaceutical Strategy, the EU Paediatric and Orphan Regulations are about to be reviewed and address shortcomings identified in a recent evaluation of the European Commission. Together with SIOP Europe, CCI